Cobra Biologics and Vaccibody sign agreement to manufacture DNA vaccine

Cobra Biologics Ltd announces an agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.

NanoKTN supports regenerative medicine development

UK regenerative medicine platform (UKRMP) safety hub announced

Biotechnology: When Proteins Change Partners

Scientists have illuminated how competition between proteins enhances combinatorial diversity during ubiquitination - the process that marks proteins for destruction.

Biotechnology: Study unveils dementia mysteries

British scientists have discovered two new genes associated with Alzheimer's disease, while French colleagues uncovered a third.

Biotechnology: New tumor marker marks resistance

Researchers have discovered a mechanism and a tumour marker for the development of this resistance.

Biotechnology: Ambitious new strategies for AIDS vaccine research

Researchers believe conventional vaccine strategies should not be the only avenue explored in the development of an effective AIDS vaccine.

Biotechnology: Zebrafish reveal secrets of addiction

A new study provides clues to the genetics that underlie susceptibility to addiction by describing the nad zebrafish mutant, which does not feel the rewarding effects of the drugs.

Biotechnology: Inching closer to corrective genes

Scientists have re-engineered a human enzyme, a protein that accelerates chemical reactions within the human body, to become highly resistant to harmful agents such as chemotherapy.

Biotechnology: Converting male germ cells

Researchers have found a way to directly convert spermatogonial stem cells, the precursors of sperm cells, into tissues of the prostate, skin and uterus.

Biotechnology: More efficient fuel production

Using electrolysed water rather than harsh chemicals could be a more effective and environmentally friendly method in the pretreatment of ethanol waste products to produce an acetone-butanol-ethanol fuel mix, according to research.

BIotechnology: Placental stem cells and lung disease

Researchers have found that stem cells derived from human placenta may ultimately play a role in the treatment of lung diseases, such as pulmonary fibrosis and fibrotic diseases caused by tuberculosis, chemical exposure, radiation or pathogens.

Biotechnology: Sticky protein reinforces membranes

A new study shows why muscle membranes don't rupture when healthy people exercise. The findings shed light on a mechanism that appears to protect cells from mechanical stress.

Biotechnology: Human cells secrete cancer-killing protein

Researchers have determined that the tumour-suppressor protein Par-4, initially thought to be active only within cells expressing the Par-4 gene, is in fact secreted by most human and rodent cells and can target large numbers of cancer cells by binding to receptors on the cell surface.

Biotechnology: Circulating cells can form bones

New research shows that specialised cells in the blood share a common origin with white blood cells derived from the bone marrow and that these bloodstream cells are capable of forming bone at sites distant from the original skeleton.

Biotechnology: No race disparities in risk of AIDS

Researchers found no disparities by race or ethnicity in risk of AIDS and death among HIV-infected patients in a setting of similar access to care.

Biotechnology: Flu virus protein damages lung cells

A protein in influenza virus that helps it multiply also damages lung epithelial cells, causing fluid buildup in the lungs, according to new research.

Biotechnology: Secrets of a life-giving amino acid

Selenium is thought to offer protection from diverse human ailments including adverse mood states, cardiovascular disease, viral infections and cancer.

Biotechnology: Possible target for Alzheimer's treatment

Researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide and may play a key role in early stages of Alzheimer's disease.

Biotechnology: New DNA repair mechanism information

Researchers have shed new light on a process that fixes breaks in the genetic material of the body's cells and could lead to ways of enhancing chemotherapy drugs.

Biotechnology: Fighting drug-resistant flu viruses

Scientists are reporting a first-of-its kind discovery that could foster a new genre of antivirals that sidestep resistance problems.






To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited